Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
Doxorubicin (DOX) has been recognized as one of the most effective chemotherapies and extensively used in the clinical settings of human cancer. However, DOX-mediated cardiotoxicity is known to compromise the clinical effectiveness of chemotherapy, resulting in cardiomyopathy and heart failure. Rece...
Na minha lista:
Main Authors: | Chayodom Maneechote (Author), Siriporn C. Chattipakorn (Author), Nipon Chattipakorn (Author) |
---|---|
Formato: | Livro |
Publicado em: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
-
Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
Por: Tanawat Attachaipanich, et al.
Publicado em: (2023) -
Corrigendum to "Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis" [Pharmacol. Res. 173 (2021) 105882]
Por: Thawatchai Khuanjing, et al.
Publicado em: (2024) -
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
Por: Thawatchai Khuanjing, et al.
Publicado em: (2023) -
Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies
Por: Panat Yanpiset, et al.
Publicado em: (2023) -
Fetal hemodynamic changes and mitochondrial dysfunction in myocardium and brain tissues in response to anemia: a lesson from hemoglobin Bart's disease
Por: Suchaya Luewan, et al.
Publicado em: (2024)